1-4 of 4
escherichia coli infections
Close
Sort by
Journal Articles

TOP2A a New Predictive Marker of Response to Carfilzomib in Multiple Myeloma

Antonia Reale, MD Oncologist in training, Tiffany Khong, BSc, PhD, Sridurga Mithraprabhu, PhD, John Reynolds, Malarmathy Ramachandran, Ioanna Savvidou, MD PhD, Krystal Bergin, Jay Hocking, MD PhDstudent, Andrew Spencer
Journal: Blood
Blood (2016) 128 (22): 4461.
https://doi.org/10.1182/blood.V128.22.4461.4461
Published: 2016
Journal Articles

TOP2A Knockdown Resensitizes Carfilzomib-Resistant Hmcls to Carfilzomib

Antonia Reale, Oncologist in training, Tiffany T. Khong, BSc, PhD, Sridurga Mithraprabhu, Post doc, Ioanna Savvidou, MD PhDstudent, Malarmathy Ramachandran, Andrew Spencer
Journal: Blood
Blood (2015) 126 (23): 4215.
https://doi.org/10.1182/blood.V126.23.4215.4215
Published: 2015
Journal Articles

Microbial messaging to the marrow

Stephanie S. Watowich
Journal: Blood
Blood (2014) 124 (9): 1379–1380.
https://doi.org/10.1182/blood-2014-07-587345
Published: 2014
Journal Articles

Active Site-Inactivated Recombinant Factor VIIa Blocks Shiga Toxin-Induced Upregulation of Tissue Factor Activity on Human Glomerular Endothelial Cells and Human Proximal Tubular Epithelial Cells.

Eirini Nestoridi, B.S., Rafail Kushak, Ph.D., Dr.Sc., Julie R. Ingelfinger, M.D., Eric F. Grabowski, M.D., Sc.D.
Journal: Blood
Blood (2004) 104 (11): 532.
https://doi.org/10.1182/blood.V104.11.532.532
Published: 2004